Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis

Journal of Molecular Endocrinology

Volumn 40, Issue 5-6, 2008, Pages 273-279

  Mencej, Simona ^a   Albagha, Omar M E ^b   Preželj, Janez ^c   Kocjan, Tomaž ^c   Marc, Janja ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR;

ADULT; AGED; ARTICLE; BONE DENSITY; CELL STRAIN HEK293; CONTROLLED STUDY; FEMALE; FEMUR NECK; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BONE DENSITY; FEMALE; HAPLOTYPES; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OSTEOPOROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PROMOTER REGIONS (GENETICS); RANK LIGAND; SOFTWARE;

EID: 45749090180     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/JME-08-0003     Document Type: Article

References (19)

1. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D & Galibert L 1997 A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390 175-179.
2. Glass DA II, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA et al. 2005 Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Developmental Cell 8 751-764.
3. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA et al. 1998 Databases on transcriptional regulation: TRANSFAC, TRRD, and COMPEL. Nucleic Acids Research 26 364-370.
4. Hofbauer LC & Heufelder AE 2001 Role of receptor activator of nuclear factor-κB ligand and osteoprotegrin in bone cell biology. Journal of Molecular Medicine 79 243-253.
5. Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, Bouxsein ML, Deng L, Clemens TL & Williams BO 2005 Essential role of beta-catenin in postnatal bone acquisition. Journal of Biological Chemistry 280 21162-21168.
6. Hsu Y, Niu T, Terwedow H, Xu X, Feng Y, Li Z, Brain JD, Rosen CJ, Laird N & Xu X 2006 Variation in genes involved in the RANKL/RANK/OPG bone remodelling pathway are associated with bone mineral density at different skeletal sites in men. Human Genetics 118 568-577.
7. International HapMap Consortium 2007 A second generation human haplotype map of over 3.1 million SNPs. Nature 449 851-861.
8. Kim JG, Kim JH, Kim JY, Ku SY, Jee BC, Suh CS, Kim SH & Choi YM 2007 Association between osteoprotegerin (OPG), receptor activator of nuclear factor-κB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause 14 913-918.
9. Knight JC 2003 Functional implications of genetic variation in non-coding DNA for disease susceptibility and gene regulation. Clinical Science 104 493-501.
10. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S et al. 1998 Osteoprotegrin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 165-176.
11. Mencej S, Prezelj J, Kocijancic A, Ostanek B & Marc J 2006 Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women. Maturitas 55 219-226.
12. Mueller JC 2004 Linkage disequilibrium for different scales and applications. Briefings in Bioinformatics 5 355-364.
13. Ralston SH & Crombrugghe B 2006 Genetic regulation of bone mass and susceptibility to osteoporosis. Genes and Development 20 2492-2506.
14. Roccisana JL, Kawanabe N, Kajiya H, Koide M, Roodman GD & Reddy SV 2004 Functional role for heat shock factors in the transcriptional regulation of human RANK ligand expression in stromal/osteoblast cells. Journal of Biological Chemistry 12 10500-10507.
15. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T et al. 1997 Osteoprotegrin: a novel secreted protein involved in the regulation of bone density. Cell 89 309-319.
16. Stephens M, Smith NJ & Donnelly P 2001 A new statistical method for haplotype reconstruction from population data. American Journal of Human Genetics 68 978-989.
17. Troen BR 2003 Molecular mechanisms underlying osteoclast formation and activation. Experimental Gerontology 38 605-614.
18. Walsh MC & Choi Y 2003 Biology of TRANCE axis. Cytokine and Growth Factor Reviews 14 251-263.
19. World Health Organisation 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO Study Group. World Health Organization Technical Report Series 843 1-129.